Controls | Patients | |||||||
---|---|---|---|---|---|---|---|---|
Group 1 | Group 2 | Group 3 | Group 4 | Total | ||||
MSS | MSI | Total | ||||||
Number | 170 | 99 | 80 | 179 | 62 | 100 | 88 | 429 |
Age range (median) | 46–92 (72) | 66–88 (67) | 25–99 (71) | 25–99 (71) | 46–62 (52) | 19–66 (42) | 70–92 (75) | 25–99 (62) |
A12 | 0.6% (0–2) | - | - | - | - | 1% (0–4) | - | 0.2%(0–1) |
A13 | 76.5% (71–81) | 70.7% (64–77) | 73.7% (66–80) | 72.1% (67–77) | 74.2% (65–81) | 73% (66–79) | 73.3% (66–79) | 72.8% (70–76) |
A14 | 22.9% (18–28) | 29.3% (23–36) | 26.3% (20–34) | 27.9% (23–33) | 25.8% (18–34) | 26% (20–33) | 26.7% (20–34) | 26.9% (24–30) |
p valueb | 0.15 | 0.46 | 0.12 | 0.90 | 0.97 | 0.30 | 0.19 |